Evidence map›Paper›PMID 15269292›Full record

ArticleThe Journal of molecular diagnostics : JMD2004

Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

Rodney N Wiltshire, James E Herndon, Annie Lloyd, Henry S Friedman, Darell D Bigner, Sandra H Bigner, Roger E McLendon

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. MET gain in diffuse astrocytomas is associated with poorer outcome.Brain pathology (Zurich, Switzerland) · 2013
    Article
  5. Article
  6. Biologic tumor behavior in pilocytic astrocytomas.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2012
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rodney N WiltshireDuke University Medical Center, Department of Pathology, Box 3712, Durham, NC 27710, USA.
James E Herndon
Annie Lloyd
Henry S Friedman
Darell D Bigner
Sandra H Bigner
Roger E McLendon
Duke Medical Center · USPediatrics and Genetics · USDuke University Hospital · US

Funding

TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMAP50NS020023 · NINDS · DUKE UNIVERSITY · PI REARDON, DAVID A · 1985 to 2013
$17.3M
BRAIN TUMORS: IMMUNOLOGICAL AND BIOLOGICAL STUDIESR37CA011898 · NCI · DUKE UNIVERSITY · PI BIGNER, DARELL D · 1988 to 2012
$8.1M
SPORE in Brain CancerP20CA096890 · NCI · DUKE UNIVERSITY · PI BIGNER, DARELL D · 2002 to 2003
$1000k
MOLECULAR MARKERS OF PROGNOSIS IN MEDULLOBLASTOMAR01CA068119 · NCI · DUKE UNIVERSITY · PI BIGNER, SANDRA H · 1996 to 2000
$343k
BRAIN TUMORS: IMMUNOLOGICAL AND BIOLOGICAL STUDIESR01CA011898 · NCI · DUKE UNIVERSITY · PI BIGNER, DARELL D · 1985 to 1987
–
NCI NIH HHS CA11898NCI NIH HHS P20 CA096890NCI NIH HHS R37 CA011898NCI NIH HHS R501-CA-68119-04NCRR NIH HHS M01 RR 30NINDS NIH HHS NS20023NINDS NIH HHS P50 NS020023
6 · The paper itself

Abstract

Astrocytoma is comprised of a group of common intracranial neoplasms that are classified into four grades based on the World Health Organization histological criteria and patient survival. To date, histological grade, patient age, and clinical performance, as reflected in the Karnofsky score, are the most reliable prognostic predictors. Recently, there has been a significant effort to identify additional prognostic markers using objective molecular genetic techniques. We believe that the identification of such markers will characterize new chromosomal loci important in astrocytoma progression and aid clinical diagnosis and prognosis. To this end, our laboratory used comparative genomic hybridization to identify DNA sequence copy number changes in 102 astrocytomas. Novel losses of 19p loci were detected in low-grade pilocytic astrocytomas and losses of loci on 9p, 10, and 22 along with gains on 7, 19, and 20 were detected in a significant proportion of high-grade astrocytomas. The Cox proportional hazards statistical modeling showed that the presence of +7q and -10q comparative genomic hybridization alterations significantly increased a patient's risk of dying, independent of histological grade. This investigation demonstrates the efficacy of comparative genomic hybridization for identifying tumor suppressor and oncogene loci in different astrocytic grades. The cumulative effect of these loci is an important consideration in their diagnostic and prognostic implications.

Indexed as

Chromosome DeletionAdolescentAdultAgedAstrocytomaBrain NeoplasmsChildChild, PreschoolChromosomes, HumanFemaleHumansInfantMaleMiddle AgedNucleic Acid HybridizationPrognosis

Identifiers

PMID15269292
PMCPMC1867634
OpenAlexW1504721566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.